Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension

Lung

Volumn 193, Issue 4, 2015, Pages 567-570

  Wellbrock, Jasmin ^a   Harbaum, Lars ^a   Stamm, Hauke ^a   Hennigs, Jan K ^a   Schulz, Björn ^a   Klose, Hans ^a   Bokemeyer, Carsten ^a   Fiedler, Walter ^a   Lüneburg, Nicole ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Biomarker; BMP antagonists; BMPR2; Bone morphogenetic protein; Gremlin 1; Pulmonary arterial hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYTOKINE RECEPTOR ANTAGONIST; GREMLIN 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN; BRAIN NATRIURETIC PEPTIDE; GREM1 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SYSTEMIC CIRCULATION; BLOOD; CASE CONTROL STUDY; EXERCISE TEST; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; SURVIVAL RATE; WALKING;

AGED; BIOMARKERS; BONE MORPHOGENETIC PROTEINS; CASE-CONTROL STUDIES; EXERCISE TEST; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, PULMONARY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PULMONARY ARTERY; SIGNAL TRANSDUCTION; SURVIVAL RATE; WALKING;

EID: 84937521023     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-015-9735-5     Document Type: Article

References (15)

1. Rabinovitch M (2012) Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 122:4306–4313
2. Hamid R, Cogan JD, Hedges LK et al (2009) Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele. Hum Mutat 30:649–654
3. Costello CM, Howell K, Cahill E et al (2008) Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 295:L272–L284
4. Cahill E, Costello CM, Rowan SC et al (2012) Gremlin plays a key role in the pathogenesis of pulmonary hypertension. Circulation 125:920–930
5. Ciuclan L, Sheppard K, Dong L et al (2013) Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice. Am J Pathol 183:1461–1473
6. Simonneau G, Gatzoulis MA, Adatia I et al (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:D34–D41
7. Mitola S, Ravelli C, Moroni E et al (2010) Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2. Blood 116:3677–3680
8. Stabile H, Mitola S, Moroni E et al (2007) Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood 109:1834–1840
9. Maciel TT, Melo RS, Schor N et al (2008) Gremlin promotes vascular smooth muscle cell proliferation and migration. J Mol Cell Cardiol 44:370–379
10. Ito A, Egashira K, Kadokami T et al (1995) Chronic inhibition of endothelium-derived nitric oxide synthesis uses coronary microvascular structural changes and hyperreactivity to serotonin in pigs. Circulation 92:2636–2644
11. Gangopahyay A, Oran M, Bauer EM et al (2011) Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation. J Biol Chem 286:33134–33140
12. Maruyama H, Dewachter C, Belhaj A et al (2014) Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension. J Heart Lung Transplant S1053-2498:01346-1
13. Mueller KA, Tavlaki E, Schneider M et al (2013) Gremlin-1 identifies fibrosis and predicts adverse outcome in patients with heart failure undergoing endomyocardial biopsy. J Card Fail 19:678–684
14. O’Reilly S, Ciechomska M, Cant R et al (2014) Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-β (TGF-β) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J Biol Chem 289:9952–9960
15. Wellbrock J, Sheikhzadeh S, Oliveira-Ferrer L et al (2014) Overexpression of Gremlin-1 in patients with Loeys-Dietz syndrome: implications on pathophysiology and early disease detection. PLoS One 9:e104742